Robert Landewé Selected Research

drotaverin (No-spa)

1/2020	What is axial spondyloarthritis? A latent class and transition analysis in the SPACE and DESIR cohorts.
12/2018	Frequency of Impaired Spinal Mobility in Patients with Chronic Back Pain Compared to Patients with Early Axial Spondyloarthritis.
1/2016	Patients with chronic back pain of short duration from the SPACE cohort: which MRI structural lesions in the sacroiliac joints and inflammatory and structural lesions in the spine are most specific for axial spondyloarthritis?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert Landewé Research Topics

Disease

45	Rheumatoid Arthritis 02/2024 - 01/2003
34	Ankylosing Spondylitis 01/2023 - 10/2002
28	Axial Spondyloarthritis 02/2024 - 10/2013
22	Inflammation (Inflammations) 05/2024 - 05/2006
15	Necrosis 02/2024 - 06/2006
13	Rheumatic Diseases (Rheumatism) 01/2020 - 08/2007
11	Psoriatic Arthritis 02/2024 - 08/2009
10	Back Pain (Backache) 02/2024 - 10/2013
9	Sacroiliitis 02/2024 - 08/2015
9	Non-Radiographic Axial Spondyloarthritis 09/2022 - 01/2016
8	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2024 - 08/2015
8	Infections 01/2020 - 06/2010
7	Arthritis (Polyarthritis) 11/2023 - 03/2010
6	Pain (Aches) 12/2021 - 08/2010
3	Nasopharyngitis 12/2018 - 09/2015
3	Osteoarthritis 09/2015 - 08/2010
2	Spondylarthropathies 05/2024 - 01/2019
2	Neoplasms (Cancer) 01/2022 - 06/2010
2	Edema (Dropsy) 01/2022 - 06/2014
2	Hepatitis B 01/2019 - 02/2017
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018 - 09/2015
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2017 - 08/2015
2	Uveitis 09/2015 - 08/2015
2	Fibromyalgia (Fibrositis) 12/2010 - 03/2002
2	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 11/2003 - 01/2003
2	Gout 11/2003 - 01/2003
1	Mycoses (Diseases, Fungus) 01/2023
1	Ankylosis 01/2022
1	Metaplasia 01/2022
1	Herpes Zoster 01/2020
1	Venous Thromboembolism 01/2020
1	Intestinal Perforation 01/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2019
1	Anterior Uveitis 01/2019
1	Crohn Disease (Crohn's Disease) 12/2018
1	Candidiasis (Moniliasis) 12/2018
1	Pneumonia (Pneumonitis) 12/2018

Drug/Important Bio-Agent (IBA)

23	Antirheumatic Agents (DMARD)IBA 02/2024 - 01/2003
17	C-Reactive ProteinIBA 02/2024 - 08/2014
13	Certolizumab Pegol FDA Link 01/2022 - 11/2008
13	Adalimumab (Humira)FDA Link 01/2020 - 01/2009
13	Methotrexate (Mexate)FDA LinkGeneric 06/2017 - 01/2003
12	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2007
11	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 01/2014
10	Interleukin-17 (Interleukin 17)IBA 01/2023 - 11/2013
9	Infliximab (Remicade)FDA Link 01/2023 - 05/2006
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 05/2006
9	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2019 - 10/2011
8	secukinumabIBA 01/2021 - 11/2013
7	Etanercept (Enbrel)FDA Link 02/2024 - 10/2006
7	GlucocorticoidsIBA 06/2017 - 03/2010
6	golimumab FDA Link 06/2017 - 07/2009
5	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 02/2024 - 10/2013
5	tofacitinibIBA 01/2022 - 01/2014
5	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2018 - 06/2005
4	bimekizumabIBA 02/2024 - 01/2019
4	Sulfasalazine (Azulfidine)FDA LinkGeneric 06/2017 - 01/2003
3	AutoantibodiesIBA 02/2024 - 09/2015
3	Proteins (Proteins, Gene)FDA Link 11/2023 - 08/2007
3	ixekizumabIBA 09/2022 - 12/2018
3	GLPG0634IBA 01/2022 - 12/2018
3	apremilastIBA 01/2021 - 01/2014
3	drotaverin (No-spa)IBA 01/2020 - 01/2016
3	tocilizumab (atlizumab)FDA Link 01/2020 - 03/2014
3	Abatacept (Orencia)FDA Link 01/2020 - 03/2014
3	Monoclonal AntibodiesIBA 12/2018 - 11/2013
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2018 - 01/2016
3	Biosimilar PharmaceuticalsIBA 06/2017 - 01/2014
3	Naproxen (Naprosyn)FDA LinkGeneric 09/2012 - 01/2003
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 11/2023 - 08/2015
2	Janus Kinase InhibitorsIBA 01/2020 - 06/2017
2	VaccinesIBA 01/2019 - 01/2019
2	Rituximab (Mabthera)FDA Link 06/2017 - 03/2014
2	Leflunomide (Arava)FDA LinkGeneric 06/2017 - 01/2014
2	baricitinibIBA 06/2017 - 01/2014
2	AntigensIBA 01/2017 - 08/2015
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2017 - 08/2007
2	Prostaglandins AIBA 07/2016 - 08/2010
2	CytokinesIBA 09/2015 - 11/2013
2	Colchicine FDA LinkGeneric 11/2003 - 01/2003
2	Diclofenac (SR 38)FDA LinkGeneric 11/2003 - 01/2003
2	Uric Acid (Urate)IBA 11/2003 - 01/2003
1	Rheumatoid FactorIBA 11/2023
1	Anti-Citrullinated Protein AntibodiesIBA 11/2023
1	AntibodiesIBA 11/2023
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	Phosphodiesterase 4 InhibitorsIBA 01/2021
1	amsonic acid (DAS)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	InterleukinsIBA 01/2019
1	insulin receptor-related receptor (IRR)IBA 01/2019
1	Janus Kinase 1IBA 12/2018
1	Creatine Kinase (Creatine Phosphokinase)IBA 12/2018

Therapy/Procedure

22	Therapeutics 01/2023 - 10/2002
5	Aftercare (After-Treatment) 01/2015 - 05/2006
2	Biological Therapy 01/2017 - 07/2011
1	Drug Tapering 09/2020